Anna Gudmundsdottir

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ACTA PAEDIATRICA. 2024;113(3):461-470

Treating very preterm European infants with inhaled nitric oxide increased in-hospital mortality but did not affect neurodevelopment at 5 years of age.

Siljehav V; Gudmundsdottir A; Tjerkaski J; Aubert AM; Cuttini M; Koopman C; Maier RF; Zeitlin J; Åden U; Screening to Improve Health in Very Preterm Infant
Article: JAMA NETWORK OPEN. 2023;6(9):e2332413

Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm.

Ehrhardt H; Aubert AM; Ådén U; Draper ES; Gudmundsdottir A; Varendi H; Weber T; Zemlin M; Maier RF; Zeitlin J; EPICE-SHIPS Research Group
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(3):667

Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.

Gudmundsdottir A; Bartocci M; Picard O; Ekström J; Chakhunashvili A; Bohlin K; Attner C; Printz G; Karlsson M; Mohlkert L-A; Karlén J; Pegelow Halvorsen C; Edstedt Bonamy A-K
Article: JAMA PEDIATRICS. 2021;175(9):911-918

Comparison of Respiratory Support After Delivery in Infants Born Before 28 Weeks' Gestational Age: The CORSAD Randomized Clinical Trial.

Donaldsson S; Drevhammar T; Li Y; Bartocci M; Rettedal SI; Lundberg F; Odelberg-Johnson P; Szczapa T; Thordarson T; Pilypiene I; Thorkelsson T; Soderstrom L; Chijenas V; Jonsson B; CORSAD Trial Investigators
Article: ACTA PAEDIATRICA. 2021;110(2):510-520

The type and timing of patent ductus arteriosus treatment was associated with neurodevelopment when extremely preterm infants reached 6.5 years.

Gudmundsdottir A; Broström L; Skiöld B; Källén K; Serenius F; Norman M; Aden U; Bonamy A-KE
Article: NEONATOLOGY. 2017;111(4):367-375

Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.

Edstedt Bonamy A-K; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M; collaborators from the EPICE Research Group
Article: NEONATOLOGY. 2015;107(2):87-92

Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.

Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy A-K

Alla övriga publikationer

Thesis / dissertation: 2019

Patent ductus arteriosus in extremely preterm infants : characteristics, risk factors and treatment decisions

Guðmundsdóttir, Anna
Letter: NEONATOLOGY. 2015;107(4):257

The importance of echocardiography and an individual approach to patent ductus arteriosus treatment in extremely preterm infants.

Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy A-K

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2022-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2019

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI